Novartis Wins FDA Approval In The U.S. To Sell Its Psoriasis Drug Cosentyx

The FDA has cleared Novartis' drug Cosentyx to treat patients with psoriasis.
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.